GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nectar Lifesciences Ltd (BOM:532649) » Definitions » 5-Year Yield-on-Cost %

Nectar Lifesciences (BOM:532649) 5-Year Yield-on-Cost % : 0.00 (As of May. 25, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Nectar Lifesciences 5-Year Yield-on-Cost %?

Nectar Lifesciences's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for Nectar Lifesciences's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Nectar Lifesciences's highest Yield on Cost was 0.63. The lowest was 0.00. And the median was 0.29.


BOM:532649's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.125
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Nectar Lifesciences's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Nectar Lifesciences's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nectar Lifesciences's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nectar Lifesciences's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Nectar Lifesciences's 5-Year Yield-on-Cost % falls into.



Nectar Lifesciences 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Nectar Lifesciences is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Nectar Lifesciences  (BOM:532649) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Nectar Lifesciences 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Nectar Lifesciences's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nectar Lifesciences (BOM:532649) Business Description

Traded in Other Exchanges
Address
SCO 38-39, Sector 9d, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009
Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.

Nectar Lifesciences (BOM:532649) Headlines

No Headlines